Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Darzalex
Pharma
J&J reports $133M in sales for new multiple myeloma med Tecvayli
For the first time, J&J is reporting sales of Tecvayli, which is off to a strong launch and contributing to the company's power in multiple myeloma.
Kevin Dunleavy
Apr 16, 2024 11:28am
GSK details combo data that could bring Blenrep back to life
Feb 5, 2024 5:00pm
Arbitrator sides with J&J, upholding Darzalex ruling vs. Genmab
Jan 23, 2024 10:23am
JPM24: J&J CEO thinks key launches can outdo analyst estimates
Jan 8, 2024 3:11pm
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Dec 12, 2023 12:00pm
AbbVie's Humira, J&J's Darzalex top ICER's annual price-hike list
Dec 11, 2023 11:26am